Research into antiviral drug development for the Human Herpesvirus 4 (HHV-4), also known as Epstein-Barr Virus, is currently underway. The thrust of these efforts revolves around formulating effective treatment options to counter the immunopathological responses and pre-empt severe manifestations of the infection. While antiviral drugs have been utilized to manage...
Discover more insightsThe Interferon market, a significant segment within the biopharmaceutical industry, is immersed in a complex milieu of both challenges and opportunities. Technological advances, evolving regulatory environments, demographic shifts, and disease prevalence trends shape this market's landscape. Interferons, proteins with antiviral properties, play a vital role in managing diseases from Hepatitis...
Discover more insights